Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 299, Issue -, Pages 118-123Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2016.09.006
Keywords
25-Hydroxyvitamin D3; Neuromyelitis optica spectrum disorder; Acute phase; Expanded Disability Status Scale
Categories
Ask authors/readers for more resources
Here, we investigated the relationship between serum 25-hydroxyvitamin D-3 (25[OH]D-3) levels and neuromyelitis optica spectrum disorder (NMOSD). Patients with NMOSD had lower 25(OH)D-3 levels than healthy people, with lower levels in patients in the acute phase than those in remission. An inverse correlation was found between 25(OH)D-3 and Expanded Disability Status Scale scores of patients during attacks. Higher serum 25(OH)D-3 levels were associated with greater amelioration of symptoms during corticosteroid therapy. These results indicate that decreased vitamin D may be involved in NMOSD pathogenesis, and that 25(OH)D-3 serum levels may reflect the severity of NMOSD in the acute phase. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available